These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37829121)
41. Health-economic burden of dementia in South Korea. Shon C; Yoon H BMC Geriatr; 2021 Oct; 21(1):549. PubMed ID: 34645415 [TBL] [Abstract][Full Text] [Related]
42. Cost of depression in Europe. Sobocki P; Jönsson B; Angst J; Rehnberg C J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486 [TBL] [Abstract][Full Text] [Related]
43. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany. Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410 [TBL] [Abstract][Full Text] [Related]
44. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385 [TBL] [Abstract][Full Text] [Related]
45. Predictors of Societal Costs in Dementia Patients and Their Informal Caregivers: A Two-Year Prospective Cohort Study. Joling KJ; Schöpe J; van Hout HP; van Marwijk HW; van der Horst HE; Bosmans JE Am J Geriatr Psychiatry; 2015 Nov; 23(11):1193-203. PubMed ID: 26238227 [TBL] [Abstract][Full Text] [Related]
46. Toward the realization of a better aged society: messages from gerontology and geriatrics. Arai H; Ouchi Y; Yokode M; Ito H; Uematsu H; Eto F; Oshima S; Ota K; Saito Y; Sasaki H; Tsubota K; Fukuyama H; Honda Y; Iguchi A; Toba K; Hosoi T; Kita T; Geriatr Gerontol Int; 2012 Jan; 12(1):16-22. PubMed ID: 22188494 [TBL] [Abstract][Full Text] [Related]
48. [Trends in the number of patients with senile dementia and need for nursing care in the upcoming 50 years--a demographic projection based on epidemiologic data for former West Germany]. Häfner H; Löffler W Offentl Gesundheitswes; 1991 Oct; 53(10):681-6. PubMed ID: 1837601 [TBL] [Abstract][Full Text] [Related]
50. Dementia prevention: current epidemiological evidence and future perspective. Mangialasche F; Kivipelto M; Solomon A; Fratiglioni L Alzheimers Res Ther; 2012 Feb; 4(1):6. PubMed ID: 22339927 [TBL] [Abstract][Full Text] [Related]
51. Projections of care for older people with dementia in England: 2015 to 2040. Wittenberg R; Hu B; Jagger C; Kingston A; Knapp M; Comas-Herrera A; King D; Rehill A; Banerjee S Age Ageing; 2020 Feb; 49(2):264-269. PubMed ID: 31808792 [TBL] [Abstract][Full Text] [Related]
52. [Family companions. New facets in accompanying relatives caring for people with dementia]. Kricheldorff C; Brijoux T Z Gerontol Geriatr; 2016 Apr; 49(3):201-8. PubMed ID: 26926149 [TBL] [Abstract][Full Text] [Related]
53. Stakeholders' perspective on issues and challenges associated with care and treatment of aging-related cognitive impairment disorders in Singapore. Setia M; Islam AM; Thompson JP; Matchar DB Int Psychogeriatr; 2011 Nov; 23(9):1421-32. PubMed ID: 21682939 [TBL] [Abstract][Full Text] [Related]
54. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population. Tscheulin DK; Drevs F Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159 [TBL] [Abstract][Full Text] [Related]
55. Projecting prevalence of frailty and dementia and the economic cost of care in Japan from 2016 to 2043: a microsimulation modelling study. Kasajima M; Eggleston K; Kusaka S; Matsui H; Tanaka T; Son BK; Iijima K; Goda K; Kitsuregawa M; Bhattacharya J; Hashimoto H Lancet Public Health; 2022 May; 7(5):e458-e468. PubMed ID: 35487231 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK. Lafuma A; Brézin A; Lopatriello S; Hieke K; Hutchinson J; Mimaud V; Berdeaux G Pharmacoeconomics; 2006; 24(2):193-205. PubMed ID: 16460138 [TBL] [Abstract][Full Text] [Related]
57. Epidemiology of Dementia: The Burden on Society, the Challenges for Research. Wolters FJ; Ikram MA Methods Mol Biol; 2018; 1750():3-14. PubMed ID: 29512062 [TBL] [Abstract][Full Text] [Related]
58. Economic costs of dementia in 11 countries in Europe: Estimates from nationally representative cohorts of a panel study. Meijer E; Casanova M; Kim H; Llena-Nozal A; Lee J Lancet Reg Health Eur; 2022 Sep; 20():100445. PubMed ID: 35781926 [TBL] [Abstract][Full Text] [Related]
59. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Schwarzkopf L; Menn P; Kunz S; Holle R; Lauterberg J; Marx P; Mehlig H; Wunder S; Leidl R; Donath C; Graessel E Value Health; 2011; 14(6):827-35. PubMed ID: 21914502 [TBL] [Abstract][Full Text] [Related]
60. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Livingston G; Kelly L; Lewis-Holmes E; Baio G; Morris S; Patel N; Omar RZ; Katona C; Cooper C Health Technol Assess; 2014 Jun; 18(39):1-226, v-vi. PubMed ID: 24947468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]